Skip to main content
Clinical Trials/TCTR20221112004
TCTR20221112004
Recruiting
N/A

Prevalence, Risk Factors and Clinical Outcomes of Sepsis Induced Myocardial Dysfunction (SIMD): A Prospective Study in King Chulalongkorn Memorial Hospital, Thailand

Faculty of Medicine, Chulalongkorn university0 sites72 target enrollmentNovember 12, 2022

Overview

Phase
N/A
Intervention
Not specified
Conditions
Sepsis induced myocardial dysfunction
Sponsor
Faculty of Medicine, Chulalongkorn university
Enrollment
72
Status
Recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
November 12, 2022
End Date
December 31, 2022
Last Updated
last year
Study Type
Observational
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Compared group
  • 1\. Admitted patients who were diagnosed as sepsis (sepsis, severe sepsis, septic shock)
  • 2\. Sepsis patients who were diagnosed as sepsis induced myocardial dysfunction
  • 3\. Aged 20\-100 years during sepsis
  • Controlled group
  • 1\. Admitted patients who were diagnosed as sepsis (sepsis, severe sepsis, septic shock)
  • 2\. Aged 20\-100 years during sepsis

Exclusion Criteria

  • 1\. Not fulfill criteria of sepsis from Sepsis\-3 definition
  • 2\. Prior history of reduced left ventricular ejection fraction (\< 40%)
  • 3\. Concurrent acute myocardial infarction
  • 4\. Echocardiogram shows stress induced cardiomyopathy
  • 5\. History of prior medications or drugs which can cause myocardial dysfunction such as doxorubicin, trastuzumab, amphetamine
  • 6\. Cardiac arrest in admission

Outcomes

Primary Outcomes

Not specified

Similar Trials